11d
The Brighterside of News on MSNAI develops life-saving snake venom treatment - helping two million people per yearEach year, over two million people fall victim to snakebites, resulting in more than 100,000 fatalities and 300,000 severe ...
12d
Hosted on MSNAI-designed proteins revolutionize snakebite treatmentResearch highlights the potential of deep learning in creating proteins that neutralize snake venom, offering new solutions ...
is a common neuromuscular junction disorder that is primarily mediated by anti-acetylcholine receptor antibodies (AChR-Ab). However, using AChR-Ab titers to predict MG severity and improvement remains ...
Early thymectomy is recommended for early-onset, generalized MG with thymic hyperplasia and acetylcholine receptor antibodies. Early thymectomy is recommended for thymoma MG. All thymus tissue ...
Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction; it is primarily caused by the production of anti-acetylcholine receptor ... IgG1 antibody Fc fragment that binds ...
The quality of immunoassays depends on the specificity and affinity of the receptor molecule (usually a monoclonal antibody) for the target; mAbs able to distinguish among the many fentanyl variants ...
The resulting computational model, known as AbMap, can predict antibody structures and binding strength based on their amino acid sequences. To demonstrate the usefulness of this model, the ...
You’ll receive it weekly for 4 weeks, followed by every 2 weeks, and is approved for people who have tested positive for anti-acetylcholine receptor antibodies. Taking eculizumab may increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results